Why the study?
Viruses depend on cellular energy metabolism for replication and Nitazoxanide interferes with both; the study tested whether mitochondrial uncoupling grounds the antiviral properties of Alinia.
Mild interference on cellular energy metabolism via mitochondrial uncoupling significantly impacts the viral replication cycle, explaining the antiviral properties of nitazoxanide.
Uncoupling may mediate Alinia's antiviral activity; leaves open clinical translation and in vivo validation.
Background Viruses are dependent on cellular energy metabolism for their replication, the drug Nitazoxanide (Alinia) was shown to interfere with both. An effect of Alinia on cellular energy metabolism is the uncoupling of mitochondrial oxidative phosphorylation (OXPHOS). Our hypothesis was that uncoupling grounds the antiviral properties of Alinia. Methods Alinia or an unrelated uncoupler were applied to a viral releasing cell line to obtain the same increasing levels of uncoupling hence identical interference with OXPHOS. Findings Decrease in infectious viral particles release reflected the intensity of interference irrespective of the nature of the drug and was significant with modest deviation (≤25%) from normal. Interpretations A mild interference on cellular energy metabolism impacts significantly on viral replication cycle. This would explain Alinia’s antiviral properties in vitro moreover antiviral action of Alinia is supported by clinical trials. Perspectives Altogether this indicates that moderate interference with mitochondrial bioenergetics should be considered as a ground for a therapeutic effect. In addition, Alinia would constitute example for a safe therapeutical use of an uncoupler, which deserves consideration for a wider range of applications.
No takes yet. Share an insight, caveat, or question.
Hammad et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: